Clark, Matthew P <br/><br/>
An aza-anthrapyrazole negatively regulates Th1 activity and suppresses experimental autoimmune encephalomyelitis.  [electronic resource] 

 -  International immunopharmacology  Feb 2016 
 - 74-87 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1878-1705 
<br/><br/><label>Standard No.: </label>10.1016/j.intimp.2015.12.014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anthracyclines--administration & dosage<br/>Apoptosis--drug effects<br/>Autoimmunity--drug effects<br/>Cell Proliferation--drug effects<br/>Cytokines--metabolism<br/>Encephalomyelitis, Autoimmune, Experimental--drug therapy<br/>Female<br/>Humans<br/>Immunosuppression Therapy<br/>Mice<br/>Mice, Inbred C57BL<br/>Mitoxantrone--administration & dosage<br/>Multiple Sclerosis--drug therapy<br/>T-Box Domain Proteins--genetics<br/>Th1 Cells--drug effects<br/>Th2 Cells--drug effects<br/>T-bet Transcription Factor